Tomas Björklund
About Tomas Björklund
Tomas Björklund is a Co-Founder and Scientific Advisor at Dyno Therapeutics and a Professor of Neuroscience at Lund University, focusing on gene therapy and neurodegenerative diseases.
Current Position at Lund University
Tomas Björklund currently holds the position of Professor of Neuroscience at Lund University in Lund, Skane County, Sweden. In this role, he focuses on advancing the understanding of basal ganglia connectomics and the development of therapies for neurological diseases, such as Parkinson's disease. His work includes mentoring PhD students and postdoctoral researchers and he has been influential in international collaborative research projects. Additionally, he serves on the editorial board of a leading neuroscience journal and has organized the annual Lund Neuroscience Symposium for the past three years.
Role at Dyno Therapeutics
At Dyno Therapeutics, Tomas Björklund serves as a Co-Founder and Scientific Advisor. In this capacity, he contributes his extensive knowledge in gene therapy and neurodegenerative diseases to advance Dyno Therapeutics’ innovative approaches. His expertise helps drive the company’s mission to develop novel genetic tools and therapeutic strategies, including AAV capsid engineering methods and in vivo genome editing technologies. His involvement underscores the importance of translating scientific research into clinical applications.
Previous Roles at Lund University
Prior to his current position, Tomas Björklund served as an Associate Professor of Neuroscience at Lund University from 2017 to 2021 and as an Assistant Professor from 2011 to 2017. Earlier in his career, he worked as a Neuroscientist at the same institution from 2009 to 2011 and began his academic journey as a PhD student from 2005 to 2009. His extensive tenure at Lund University has allowed him to make significant contributions to the field of neuroscience and gene therapy.
Academic Background
Tomas Björklund’s academic journey began at Lund University, where he attained a Master of Medicine in Biomedicine from 1998 to 2005 and a PhD in Neuroscience from 2005 to 2009. He also attended The Faculty of Engineering at Lund University from 2002 to 2003. His early education was completed at Katedralskolan Lund from 1995 to 1998. Throughout his academic studies, he developed a strong foundation that has supported his research and professional achievements in neuroscience and gene therapy.
Professional Contributions and Achievements
Tomas Björklund has co-authored several research papers on gene therapy and neurodegenerative diseases, contributing valuable knowledge to the field. He developed a novel gene delivery system, which has been patented and is currently utilized in clinical trials. He received the prestigious Wallenberg Academy Fellow award for his contributions to neuroscience. Additionally, he holds a number of pending and awarded patents in gene therapy. Björklund has delivered keynote speeches at major neuroscience conferences and currently serves as the President of the Swedish Society for Neuroscience since 2016.
Industry Experience
Besides his academic roles, Tomas Björklund has substantial experience in the industry. He worked as Chief Operating Officer at Genepod Therapeutics AB from 2010 to 2019, where he played a pivotal role in translating gene therapy for Parkinson’s disease towards clinical application. His industry experience also includes working as a consultant at e-merge.se from 2000 to 2009. Björklund’s industry expertise complements his academic pursuits, enhancing his overall contributions to the field of neuroscience and gene therapy.